Powder & Bulk Solids is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

TUMS Tablets Recalled Due to Contamination

Image courtesy of Pixabay (representative image) Tums_PIXABAY.jpg
Some tablets were found to contain fragments of fibreglass and other material

GlaxoSmithKline Consumer Healthcare ULC is recalling one lot of TUMS Peppermint Regular Strength tablets after some tablets were found to contain fragments of fibreglass and other material, including paper and aluminum foil. 

The product was distributed across Canada starting on October 25, 2022, and is sold in a package of three rolls containing 12 tablets each.

TUMS is an antacid indicated for adults that is intended to relieve indigestion and heartburn. If consumed, the fragments should pass through most people's digestive systems with no concern. However, elderly people and people with narrow areas in their intestines because of disease or surgery may be at risk of injury.

Health Canada is monitoring the recall and will update the public if any new risks are identified.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.